Insmed announces positive results from Phase III arise study of ARIKAYCE
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
        Subscribe To Our Newsletter & Stay Updated